MedPath

A Prospective Observational Study of Stereotactic Body Radiotherapy for Favorable Risk Prostate Cancer

Not Applicable
Recruiting
Conditions
Prostate cancer
Registration Number
JPRN-UMIN000045391
Lead Sponsor
Iwate medical university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Treated with brachytherapy 2) Received anti-androgen therapy for more than 1 year 3) After radical prostatectomy 4) MRI cannot be performed 5) Inflammatory bowel disease 6) Bilateral total hip arthroplasty 7) Synchronous or metachronous malignancies 8) Prostate volume larger than 80 cm3 on planning CT 9) Patients who attending physicians consider to be inappropriate due to other reasons mentioned above

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Five-year biochemical relapse-free survival
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath